Celgene, OncoMed in $177M Cancer Stem Cell DealPharmaLive (press release) (subscription)3, 2013 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED) and Celgene Corporation (Nasdaq:CELG) today announced an agreement to jointly develop and commercialize up to six anti-cancer stem cell (CSC) product candidates from … …read more &nbs… Continue reading
StemGenex(r) Continues to Announce Groundbreaking Stem Cell Therapies for …NewsdayStemGenex… Continue reading
Scientists Use Human Stem Cells To Make Lung TissueHuffington PostHuman stem cells have been converted into functioning lung cells for the first time, paving the way for better models of lung diseases, ways to test potential drugs and, ultimately, creation of tissue for lung transplants. Scientists had previously … …read more &nbs… Continue reading
Record – Columbia News (blog)NEW YORK, NY — For the first time, scientists have succeeded in transforming human stem cells into functional lung and airway cells. The advance, reported by Columbia University Medical Center (CUMC) researchers, has significant potential for modeling …Converting stem cells into lung cellsMedical News TodayScientists Use Stem Cells to Create Lung … Continue reading
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell DrugsXconomyOncoMed Pharmaceuticals (NASDAQ: OMED) may be a long ways away from actually winning FDA approval of a product, but it just got a big vote of confidence from Celgene that it’s on the right track with its cancer stem cell work. Celgene (NASDAQ: CELG) …OncoMed, Celgene … Continue reading
California Stem Cell Announces U.S. FDA Approval of Phase III Cancer Stem …4-traders (press release)California Stem Cell, Inc. (CSC) announced today that the U.S. Food and Drug Administration (FDA) has approved the Company’s application to begin a Phase III clinical trial exploring the potential of a cancer stem cell-based platform therapy to treat … …read … Continue reading
Maryland Stem Cell Research Commission Presents Sixth Annual Maryland …PR Newswire (press release)BALTIMORE, Dec. 3, 2013 /PRNewswire/ — Each year, the State of Maryland continues to lead advancements and best practices in U.S. stem cell research through the Maryland Stem Cell Research Fund (MSCRF). To celebrate and share the most current … and more …read … Continue reading
OncoMed, Celgene To Jointly Advance Multiple Anti-Cancer Stem Cell …NASDAQ(RTTNews.com) – OncoMed Pharmaceuticals, Inc. ( OMED ) and Celgene Corp. ( CELG ) announced an agreement to jointly develop and commercialize up to six anti-cancer stem cell or CSC product candidates from OncoMed’s biologics pipeline, including …Celgene commits $3.3B in whopper cancer stem cell deal … Continue reading